Wegovy can reduce heart failure symptoms in obese patients, study shows
Novo Nordisk is eyeing the cardiology treatment space for its highly sought-after drug that is dominating the weight loss and diabetes drug landscape.
Novo Nordisk is eyeing the cardiology treatment space for its highly sought-after drug that is dominating the weight loss and diabetes drug landscape.
What's Your Reaction?
